Article Details

Texas A&M Researchers Lead Study Of COVID-19 Blocking Enzyme

Retrieved on: 2021-04-12 18:45:00

Tags for this article:

Click the tags to see associated articles and topics

Texas A&M Researchers Lead Study Of COVID-19 Blocking Enzyme. View article details on hiswai:

Excerpt

... of the antiviral drug remdesivir and an emergency use authorization for monoclonal antibodies in treating more serious cases of COVID-19.

Article found on: today.tamu.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo